Reversing advanced heart failure by targeting Ca2+ cycling

Annual Review of Medicine
David M KayeKenneth R Chien

Abstract

Heart failure is a major cardiovascular disease, characterized by considerable morbidity and mortality. Despite major advances in the pharmacotherapy of heart failure, the options for patients with severe end-stage symptoms remain limited. However, recent developments in the identification of the molecular basis for the progressive nature of heart failure have identified a number of potentially important new therapeutic targets. In particular, key components of the cardiomyocyte calcium-handling pathway show characteristic changes in heart failure. A body of research examining the effect of restoration of these defects in experimental models of heart failure, whether in genetically engineered mouse models or by myocardial gene transfer, very strongly supports the calcium-handling pathway as a target for clinical intervention.

References

May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·J M PfefferE Braunwald
Jul 22, 1982·The New England Journal of Medicine·M R BristowE B Stinson
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Nov 1, 1995·Journal of the American College of Cardiology·D M KayeM D Esler
Sep 1, 1995·The Journal of Clinical Investigation·L S ZismanM V Raynolds
Jan 15, 1995·Circulation·E G Nabel
Apr 17, 1997·The New England Journal of Medicine·G OlivettiP Anversa
Jun 6, 1998·Cardiovascular Research·G Hasenfuss
Sep 16, 1998·The American Journal of Cardiology·J KajsturaP Anversa
Oct 21, 1999·The New England Journal of Medicine·J J Hunter, K R Chien
Oct 26, 1999·Cardiovascular Research·G F Tomaselli, E Marbán
Nov 26, 1999·Circulation Research·R P XiaoE G Lakatta
Feb 3, 2000·Proceedings of the National Academy of Sciences of the United States of America·T TaigenJ D Molkentin
Jul 11, 2000·Journal of Molecular and Cellular Cardiology·Y YangS R Houser
Dec 23, 2000·The Journal of Biological Chemistry·T SorsaI Kilpelainen
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·L A Leinwand
Apr 5, 2001·European Heart Journal·J G ClelandA Clark
Jul 12, 2001·Circulation·M J DavidsonC A Milano

❮ Previous
Next ❯

Citations

May 7, 2009·Antioxidants & Redox Signaling·Ebo D de Muinck
Sep 14, 2010·Cardiovascular Research·Mayilvahanan ShanmugamGopal J Babu
Oct 11, 2008·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Gudrun Antoons, Karin R Sipido
Jan 12, 2010·Annual Review of Medicine·Cesare M TerraccianoMagdi H Yacoub
Mar 26, 2014·Pflügers Archiv : European journal of physiology·James D GladdenMargaret M Redfield
Jan 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Zhengxian TaoHua Su
Aug 11, 2017·Molecular BioSystems·Phonindra Nath DasSamrat Chatterjee
May 21, 2014·Circulation. Heart Failure·Mosi K BennettChristine S Moravec
Jun 10, 2017·Circulation Research·Andrew P LandstromXander H T Wehrens
May 16, 2008·Nature·Kenneth R Chien
Aug 14, 2009·Expert Review of Cardiovascular Therapy·Sabine Telemaque, James D Marsh
Jan 28, 2014·American Journal of Physiology. Heart and Circulatory Physiology·Jennifer K MacDonaldSusan E Howlett
Aug 23, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Munetaka ShibataMiyako Takaki
Jan 12, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Carolyn A HolladayAbhay Pandit
Dec 9, 2015·Proceedings of the National Academy of Sciences of the United States of America·Tielin ZhouBaojie Li

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
pharmacotherapy

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.